Latest news
{{'2026-01-05T13:00:00Z' | dateFormatFilter}}
Novo Nordisk's Wegovy® pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America
{{'2025-12-31T13:24:42Z' | dateFormatFilter}}
Novo Nordisk A/S: China’s Supreme People’s Court delivers a positive ruling on the semaglutide compound patent
{{'2025-12-22T22:50:36Z' | dateFormatFilter}}
Novo Nordisk A/S: Wegovy® pill approved in the US as first oral GLP-1 for weight management
Investors
Share price
{{priceData.date}} {{priceData.time}}
{{priceData.currentPrice}}
{{priceData.currency}}
Go to stock watch
{{priceData.change}} {{priceData.currency}}
